To Become Effective Lobbyists, Scientists Seek Alliances With Patient Advocates
In Brief: Joseph Bertino Succeeds Bresnick As AACR President; Louise Strong Is President-Elect
Dana-Farber Accepts Responsibility For Death Of One Patient, Harm To Another
FDA Recruiting ODAC Consumer Rep Candidates
IOM: No Negligence In FIAU Clinical Trial That Killed Five
ACS Clinical Awards Available For 1996
ONF Seeks Applications For Grants In Fatigue
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









